Roopa Trivedi

1.4k total citations · 1 hit paper
30 papers, 901 citations indexed

About

Roopa Trivedi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Roopa Trivedi has authored 30 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Roopa Trivedi's work include Inhalation and Respiratory Drug Delivery (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers) and Asthma and respiratory diseases (18 papers). Roopa Trivedi is often cited by papers focused on Inhalation and Respiratory Drug Delivery (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers) and Asthma and respiratory diseases (18 papers). Roopa Trivedi collaborates with scholars based in United States, United Kingdom and Sweden. Roopa Trivedi's co-authors include Paul Dorinsky, Patrick Darken, Magnus Aurivillius, Klaus F. Rabe, Dave Singh, Gary T. Ferguson, Shaila Ballal, Colin Reisner, Earl St. Rose and Chen Wang and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Roopa Trivedi

29 papers receiving 872 citations

Hit Papers

Triple Inhaled Therapy at Two Glucocorticoid Doses in Mod... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roopa Trivedi United States 12 781 588 50 48 38 30 901
Vanesa Lores Spain 9 561 0.7× 323 0.5× 88 1.8× 71 1.5× 21 0.6× 16 685
Vidya Krishnan United States 11 296 0.4× 361 0.6× 21 0.4× 160 3.3× 29 0.8× 22 546
Eleni Karetsi Greece 12 279 0.4× 148 0.3× 42 0.8× 63 1.3× 28 0.7× 33 426
A.S. Vathenen United Kingdom 9 535 0.7× 561 1.0× 20 0.4× 9 0.2× 12 0.3× 10 734
E.C. Creutzberg Netherlands 7 383 0.5× 235 0.4× 20 0.4× 22 0.5× 19 0.5× 11 467
Laurie A. Waterman United States 12 524 0.7× 271 0.5× 47 0.9× 38 0.8× 16 0.4× 17 567
Vittorio Cardaci Italy 12 324 0.4× 121 0.2× 40 0.8× 11 0.2× 9 0.2× 28 464
Paul Deegan Ireland 9 231 0.3× 173 0.3× 23 0.5× 146 3.0× 30 0.8× 17 370
Paweł Nastałek Poland 9 180 0.2× 173 0.3× 22 0.4× 51 1.1× 21 0.6× 22 313
Lili Guan China 13 239 0.3× 46 0.1× 26 0.5× 22 0.5× 28 0.7× 36 416

Countries citing papers authored by Roopa Trivedi

Since Specialization
Citations

This map shows the geographic impact of Roopa Trivedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roopa Trivedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roopa Trivedi more than expected).

Fields of papers citing papers by Roopa Trivedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roopa Trivedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roopa Trivedi. The network helps show where Roopa Trivedi may publish in the future.

Co-authorship network of co-authors of Roopa Trivedi

This figure shows the co-authorship network connecting the top 25 collaborators of Roopa Trivedi. A scholar is included among the top collaborators of Roopa Trivedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roopa Trivedi. Roopa Trivedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Usmani, Omar S., Nicolás Roche, Samuel Israel, et al.. (2021). A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory Research. 22(1). 261–261. 11 indexed citations
4.
5.
Martínez, Fernando J., Klaus F. Rabe, Gary T. Ferguson, et al.. (2021). Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. Respiratory Medicine. 185. 106509–106509. 12 indexed citations
6.
Martínez, Fernando J., Klaus F. Rabe, Gary T. Ferguson, et al.. (2020). Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. American Journal of Respiratory and Critical Care Medicine. 203(5). 553–564. 147 indexed citations
9.
Dorinsky, Paul, Paolo B. DePetrillo, Kiernan DeAngelis, et al.. (2020). Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults. Clinical Therapeutics. 42(4). 634–648. 9 indexed citations
10.
Rabe, Klaus F., Fernando J. Martinez, Gary T. Ferguson, et al.. (2020). Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. New England Journal of Medicine. 383(1). 35–48. 374 indexed citations breakdown →
12.
Feldman, Gregory, François Maltais, Sanjeev Khindri, et al.. (2016). A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD. International Journal of COPD. 11. 719–719. 39 indexed citations
13.
Lee, Laurie A., Shuying Yang, Edward Kerwin, et al.. (2014). The effect of fluticasone furoate/umeclidinium in adult patients with asthma: A randomized, dose-ranging study. Respiratory Medicine. 109(1). 54–62. 45 indexed citations
14.
Trivedi, Roopa, Nathalie Richard, Rashmi Mehta, & Alison Church. (2013). Umeclidinium in patients with COPD: a randomised, placebo-controlled study. European Respiratory Journal. 43(1). 72–81. 75 indexed citations
15.
Lincourt, William R., et al.. (2010). Repeat Dosing of Albuterol via Metered-Dose Inhaler in Infants With Acute Obstructive Airway Disease. Pediatric Emergency Care. 26(3). 197–202. 9 indexed citations
16.
Hedrick, James, James Baker, Arthur B. Atlas, et al.. (2009). Safety of Daily Albuterol in Infants with a History of Bronchospasm: A Multi-Center Placebo Controlled Trial§. The Open Respiratory Medicine Journal. 3(1). 100–106. 4 indexed citations
17.
Kerwin, Edward, Martha Tarpay, Michael Noonan, et al.. (2006). Safety and Efficacy of a New Albuterol Hydrofluoroalkane Formulation for Treating Asthma Symptoms in Children Two to Less Than Four Years of Age. Pediatric Asthma Allergy & Immunology. 19(2). 81–90. 2 indexed citations
18.
Kalhan, Satish C., Roopa Trivedi, Sheila K. Singh, et al.. (1995). A micromethod for the measurement of deuterium bound to carbon‐6 of glucose to quantify gluconeogenesis in vivo. Journal of Mass Spectrometry. 30(11). 1588–1592. 23 indexed citations
19.
Mitra, J., et al.. (1992). Cardiorespiratory changes induced by vertebral artery injection of sodium cyanide in cats. Respiration Physiology. 87(1). 49–61. 12 indexed citations
20.
Haxhiu, Musa A., E. C. Deal, Roopa Trivedi, Erik van Lunteren, & Neil S. Cherniack. (1988). Tracheal and phrenic responses to neurotensin applied to ventral medulla. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 255(5). R780–R786. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026